Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

640.90INR
20 Jan 2017
Change (% chg)

-- (--)
Prev Close
Rs640.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
450,882
52-wk High
Rs898.00
52-wk Low
Rs572.40

Latest Key Developments (Source: Significant Developments)

Sun Pharma to buy Novartis' cancer drug Odomzo
Wednesday, 21 Dec 2016 10:01pm EST 

Sun Pharmaceutical Industries Ltd : Says Sun Pharma to acquire branded oncology product Odomzo for global markets . Says acquisition of Odomzo from Novartis . Says greement has been signed for an upfront payment of US$ 175 million and additional milestone payments. .says Odomzo is used for treatment of adult patients with labcc that has recurred following surgery or radiation therapy.  Full Article

Sun Pharmaceutical Industries announces voluntary withdrawal of 28 ANDAs
Monday, 19 Dec 2016 09:48pm EST 

Sun Pharmaceutical Industries Ltd : Says older drug products belong to erstwhile ranbaxy laboratories ltd. And are not being marketed in us since 2008 .Says voluntary withdrawal of 28 ANDAs.  Full Article

Sun Pharmaceutical Industries says USFDA cites nine inspectional observations at Halol facility
Thursday, 8 Dec 2016 04:15am EST 

Sun Pharmaceutical Industries Ltd : USFDA inspected the company's Halol facility in Gujarat, India from November 17, 2016 through December 1, 2016 . At the conclusion of the inspection, the USFDA issued a Form-483, citing nine inspectional observations . Says intends to implement promptly any corrective actions that may be necessary as a result of the observations .None of the observations were characterized by the USFDA as repeat observations.  Full Article

Sun Pharma enters into deal to buy 85.1 pct of Russia's JSC Biosintez
Tuesday, 22 Nov 2016 09:51pm EST 

Sun Pharmaceutical Industries Ltd : Says company has entered into an agreement to acquire 85.1% of JSC Biosintez, a Russian pharmaceutical company . Days deal expected to be completed by end of 2016 . Equity consideration for shares acquired is RUB 1,526 million or approx. USD 24 million .Sun Pharma would also assume a debt of approximately USD$ 36 million as part of this transaction.  Full Article

Sun Pharmaceutical Industries signs tri-party agreement to launch malaria free India
Tuesday, 15 Nov 2016 03:41am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries Ltd says Sun Pharma signing tri-party agreement to launch malaria free India . Sun Pharmaceutical Industries -agreement allows other government or private stakeholders to join Mandla project,similar project in partnership with FDEC-India . Sun Pharmaceutical Industries - ICMR, government of MP, FDEC-India sign tri-party agreement to launch malaria free India demonstration project in Mandla district .Sun Pharmaceutical Industries - project to be launched across 1,233 villages in Mandla by january 2017.  Full Article

Beijing Science Sun Pharmaceutical unit to pay penalty of 0.3 mln yuan
Friday, 19 Aug 2016 04:05am EDT 

Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>: Says its unit received report of administrative punishment from environmental protection department .Says the unit was ordered to pay penalty of about 0.3 million yuan regarding its wastewater discharge.  Full Article

Sun Pharmaceutical Industries June-qtr consol profit rises almost fourfold
Friday, 12 Aug 2016 04:46am EDT 

Sun Pharmaceutical Industries Ltd : June-quarter consol net profit 20.34 billion rupees . June-quarter consol total income from operations 82.43 billion rupees . June-quarter net profit consensus forecast was 19.04 billion rupees . Consol net profit in June-quarter last year was 5.56 billion rupees as per Ind-AS; consol net sales was 67.61 billion rupees .  Full Article

Sun Pharmaceutical extends Imatinib Mesylate Savings Card program benefits for patients in USA
Monday, 8 Aug 2016 08:32am EDT 

Sun Pharmaceutical Industries Ltd : Sun Pharma extends Imatinib Mesylate Savings Card program benefits for patients in USA . Co will continue to offer up to US$ 700 reduction on each eligible patient's initial out-of-pocket cost from their commercial insurer . Benefit will cover a patient's monthly fills for a 30-day supply of Sun pharma's imatinib mesylate prescribed for ph+cml, . Will also continue hub service wherein patients can call and speak with a trained healthcare professional .  Full Article

India's Sun Pharma gets FDA nod for generic Glumetza
Monday, 1 Aug 2016 11:44pm EDT 

Sun Pharmaceutical Industries Ltd : Sun Pharma announces U.S. FDA approval for generic Glumetza . The commercial launch of the tablets in the U.S. is expected over the next few weeks .  Full Article

Sun Pharma and Almirall signs license deal for Psoriasis treatment
Wednesday, 27 Jul 2016 10:32pm EDT 

Sun Pharmaceutical Industries Ltd : Almirall and Sun Pharma enter into a license agreement for Tildrakizumab in Europe for Psoriasis . To receive development & regulatory milestone payments, royalties, the terms of which are confidential .  Full Article

Photo

U.S. states sue Mylan, Teva, others for fixing drug prices

WASHINGTON Two years after high generic drug prices became a public controversy, legal cases are starting to land.